4.8 Article

EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells

Journal

CANCER RESEARCH
Volume 76, Issue 21, Pages 6396-6409

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-16-0225

Keywords

-

Categories

Funding

  1. NCI NIH HHS [P30 CA046592] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL096384] Funding Source: Medline
  3. NIDCR NIH HHS [K08 DE026500] Funding Source: Medline
  4. NIGMS NIH HHS [T32 GM007315] Funding Source: Medline
  5. NIH HHS [DP2 OD004197] Funding Source: Medline

Ask authors/readers for more resources

Little is known about the factors that regulate the asymmetric division of cancer stem-like cells (CSC). Here, we demonstrate that EGFL6, a stem cell regulatory factor expressed in ovarian tumor cells and vasculature, regulates ALDH(+) ovarian CSC. EGFL6 signaled at least in part via the oncoprotein SHP2 with concomitant activation of ERK. EGFL6 signaling promoted the migration and asymmetric division of ALDH(+) ovarian CSC. As such, EGFL6 increased not only tumor growth but also metastasis. Silencing of EGFL6 or SHP2 limited numbers of ALDH(+) cells and reduced tumor growth, supporting a critical role for EGFL6/SHP2 in ALDH(+) cell maintenance. Notably, systemic administration of an EGFL6-neutralizing antibody we generated restricted tumor growth and metastasis, specifically blocking ovarian cancer cell recruitment to the ovary. Together, our results offer a preclinical proof of concept for EGFL6 as a novel therapeutic target for the treatment of ovarian cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Peripheral Vascular Disease

Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation

Timothy D. Le Cras, Jillian Goines, Nora Lakes, Patricia Pastura, Adrienne M. Hammill, Denise M. Adams, Elisa Boscolo

ANGIOGENESIS (2020)

Article Oncology

Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels

Janet Crane, Jackie Manfredo, Elisa Boscolo, Mara Coyan, Clifford Takemoto, Maxim Itkin, Denise M. Adams, Timothy D. Le Cras

PEDIATRIC BLOOD & CANCER (2020)

Article Medicine, General & Internal

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta, Salim S. Hayek, Wei Wang, Lili Chan, Kusum S. Mathews, Michal L. Melamed, Samantha K. Brenner, Amanda Leonberg-Yoo, Edward J. Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Anand Srivastava, Yan Zhou, Anne Sutherland, Adam Green, Alexandre M. Shehata, Nitender Goyal, Anitha Vijayan, Juan Carlos Q. Velez, Shahzad Shaefi, Chirag R. Parikh, Justin Arunthamakun, Ambarish M. Athavale, Allon N. Friedman, Samuel A. P. Short, Zoe A. Kibbelaar, Samah Abu Omar, Andrew J. Admon, John P. Donnelly, Hayley B. Gershengorn, Miguel A. Hernan, Matthew W. Semler, David E. Leaf

JAMA INTERNAL MEDICINE (2020)

Article Urology & Nephrology

AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19

Shruti Gupta, Steven G. Coca, Lili Chan, Michal L. Melamed, Samantha K. Brenner, Salim S. Hayek, Anne Sutherland, Sonika Puri, Anand Srivastava, Amanda Leonberg-Yoo, Alexandre M. Shehata, Jennifer E. Flythe, Arash Rashidi, Edward J. Schenck, Nitender Goyal, S. Susan Hedayati, Rajany Dy, Anip Bansal, Ambarish Athavale, H. Bryant Nguyen, Anitha Vijayan, David M. Charytan, Carl E. Schulze, Min J. Joo, Allon N. Friedman, Jingjing Zhang, Marie Anne Sosa, Eric Judd, Juan Carlos Q. Velez, Mary Mallappallil, Roberta E. Redfern, Amar D. Bansal, Javier A. Neyra, Kathleen D. Liu, Amanda D. Renaghan, Marta Christov, Miklos Z. Molnar, Shreyak Sharma, Omer Kamal, Jeffery Owusu Boateng, Samuel A. P. Short, Andrew J. Admon, Meghan E. Sise, Wei Wang, Chirag R. Parikh, David E. Leaf

Summary: The study found that AKI-RRT is common among critically ill patients with COVID-19, with a mortality rate of over 50%. For patients with AKI-RRT, older age, severe oliguria, and admission to a hospital with fewer ICU beds or higher density of COVID-19 were associated with higher 28-day mortality rates.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI

Tariq U. Azam, Husam R. Shadid, Pennelope Blakely, Patrick O'Hayer, Hanna Berlin, Michael Pan, Peiyao Zhao, Lili Zhao, Subramaniam Pennathur, Rodica Pop-Busui, Izzet Altintas, Jens Tingleff, Marius A. Stauning, Ove Andersen, Maria-Evangelia Adami, Nicky Solomonidi, Maria Tsilika, Pinkus Tober-Lau, Eleni Arnaoutoglou, Verena Keitel, Frank Tacke, Athanasios Chalkias, Sven H. Loosen, Evangelos J. Giamarellos-Bourboulis, Jesper Eugen-Olsen, Jochen Reiser, Salim S. Hayek

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Medicine, General & Internal

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

Salim S. Hayek, Samantha K. Brenner, Tariq U. Azam, Husam R. Shadid, Elizabeth Anderson, Hanna Berlin, Michael Pan, Chelsea Meloche, Rafey Feroz, Patrick O'Hayer, Rayan Kaakati, Abbas Bitar, Kishan Padalia, Daniel Perry, Pennelope Blakely, Shruti Gupta, Shahzad Shaefi, Anand Srivastava, David M. Charytan, Anip Bansal, Mary Mallappallil, Michal L. Melamed, Alexandre M. Shehata, Jag Sunderram, Kusum S. Mathews, Anne K. Sutherland, Brahmajee K. Nallamothu, David E. Leaf

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta, Wei Wang, Salim S. Hayek, Lili Chan, Kusum S. Mathews, Michal L. Melamed, Samantha K. Brenner, Amanda Leonberg-Yoo, Edward J. Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Anand Srivastava, Yan Zhou, Diana Finkel, Adam Green, Mary Mallappallil, Anthony J. Faugno, Jingjing Zhang, Juan Carlos Q. Velez, Shahzad Shaefi, Chirag R. Parikh, David M. Charytan, Ambarish M. Athavale, Allon N. Friedman, Roberta E. Redfern, Samuel A. P. Short, Simon Correa, Kapil K. Pokharel, Andrew J. Admon, John P. Donnelly, Hayley B. Gershengorn, David J. Douin, Matthew W. Semler, Miguel A. Hernan, David E. Leaf

Summary: A multicenter cohort study found that early treatment with tocilizumab may reduce mortality among critically ill patients with COVID-19. Further research from randomized clinical trials is needed to confirm these findings.

JAMA INTERNAL MEDICINE (2021)

Article Medicine, Research & Experimental

NOGOB receptor mediated RAS signaling pathway is a target for suppressing proliferating hemangioma

Wenquan Hu, Zhong Liu, Valerie Salato, Paula E. North, Joyce Bischoff, Suresh N. Kumar, Zhi Fang, Sujith Rajan, M. Mahmood Hussain, Qing R. Miao

Summary: Infantile hemangioma is characterized by rapid growth and slow involution of disorganized blood vessels. NGBR was found to be highly expressed in the proliferating phase of hemangioma but decreased in the involuting phase. Knockdown of NGBR in HemSCs attenuated RAS activation and inhibited cell migration and proliferation, suggesting its role in controlling growth and differentiation of hemangioma stem cells.

JCI INSIGHT (2021)

Article Hematology

Endothelial-Mesenchymal Transition in Cardiovascular Disease

Zahra Alvandi, Joyce Bischoff

Summary: Endothelial-to-mesenchymal transition is a dynamic process where endothelial cells transition to mesenchymal cells, starting with loosening and migration, ultimately leading to decreased endothelial functions. This process plays a critical role in inflammation, angiogenesis, and cardiovascular diseases, affecting cell function and tissue integrity.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Peripheral Vascular Disease

NRAS(Q61R) mutation in human endothelial cells causes vascular malformations

Elisa Boscolo, Patricia Pastura, Sandra Schrenk, Jillian Goines, Rachael Kang, Devin Pillis, Punam Malik, Timothy D. Le Cras

Summary: This study demonstrates that somatic mutations in NRAS can drive abnormal angiogenesis in human endothelial cells. The researchers developed in vitro and in vivo models to identify disease-causing pathways and test inhibitors. Treatment with a MAP kinase inhibitor prevented the abnormal changes caused by the NRAS(Q61R) mutation.

ANGIOGENESIS (2022)

Article Medicine, General & Internal

Evolution of Care and Outcomes Across Surges in Hospitalized Patients with Coronavirus Disease 2019

Patrick J. O'Hayer, Alexi Vasbinder, Elizabeth Anderson, Tonimarie Catalan, Brayden Bitterman, Ibrahim Khaleel, Grace Erne, Annika Tekumulla, Caroline Tilley, Feriel Presswalla, Namratha Nelapudi, Jiazi Chen, Medha Tripathi, Matthew Rochlen, Loni Rambo, Noor Sulaiman, Pennelope Blakely, Yiyuan Huang, Lili Zhao, Rodica Pop-Busui, Salim S. Hayek

Summary: The study found that COVID-19 patients in different stages had different characteristics and treatment approaches. The burden of comorbidities and inflammation decreased over time, leading to improved clinical outcomes.

AMERICAN JOURNAL OF MEDICINE (2023)

Editorial Material Hematology

Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)-Induced Vascular Permeability

Joyce Bischoff

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)

Article Hematology

CD45 Is Sufficient to Initiate Endothelial-to-Mesenchymal Transition in Human Endothelial Cells-Brief Report

Sana Nasim, Jill Wylie-Sears, Xinlei Gao, Qianman Peng, Bo Zhu, Kaifu Chen, Hong Chen, Joyce Bischoff

Summary: Endothelial-to-mesenchymal transition (EndMT) is a dynamic process in which endothelial cells acquire mesenchymal properties and contribute to tissue remodeling and growth. CD45 is identified as a potential regulator of EndMT, as its inhibition blocks TGF-beta-induced EndMT. Activation of CD45 induces the EndMT phenotype and acquisition of mesenchymal cell properties in normal human endothelial cells.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

Meeting Abstract Endocrinology & Metabolism

Case Report of Clinical Improvement in Patient with Kaposiform Lymphangiomatosis Treated with Sirolimus and Adjunctive Zoledronate

Jacquelyn Manfredo, Clifford Takemoto, Elisa Boscolo, Denise Adams, Timothy LeCras, Janet Crane

HORMONE RESEARCH IN PAEDIATRICS (2020)

Article Medicine, Research & Experimental

NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer

Alexander J. Cole, Mangala Iyengar, Santiago Panesso-Gomez, Patrick O'Hayer, Daniel Chan, Greg M. Delgoffe, Katherine M. Aird, Euisik Yoon, Shoumei Bai, Ronald J. Buckanovich

JCI INSIGHT (2020)

No Data Available